Director – Life Sciences
Iterative Health
Director – Life Sciences
Iterative Health
AI-powered polyp detection for colorectal cancer
Iterative Health is a healthcare technology and services company powering the acceleration of clinical research to transform patient outcomes.
We built a leading performance-driven network of 100+ sites across the US, Europe, India, and Australia, conducting research directly in the communities where care is delivered across gastrointestinal, hepatology, obesity, and cardiology. By combining deep clinical trial expertise with cutting-edge AI, we connect sponsors' scientific ambitions with high-performing research teams that expedite and expand access to novel therapeutics for patients in need. Today, Iterative Health is headquartered in Cambridge, Massachusetts, and New York City with 250+ employees world-wide.
As a Director, Life Sciences at Iterative Health you will play a pivotal role in accelerating growth across our clinical trials business. This highly visible, external-facing role will be responsible for identifying, developing, and expanding partnerships with biopharmaceutical and biotechnology sponsors, helping bring innovative therapies to patients through cutting-edge clinical research.
You will own the full business development lifecycle—from market engagement and opportunity identification through proposal development, contract negotiation, and partnership expansion. This individual will collaborate closely with clinical operations, product, scientific, and executive leadership teams to develop commercial strategies that drive revenue growth and strengthen Iterative Health's position as a trusted partner in driving innovations in specialty research.
Where You’ll Drive Impact
At Iterative Health, we’re actively working towards creating an environment that is representative of the diversity of patients our technology serves. We are focused on building an equitable and inclusive culture, and by extension, hiring process. If you require any accommodations to make the application process or interviewing experience more accessible to you, please contact [email protected].
New York pay range 180000 - 250000 USD
AI-powered polyp detection for colorectal cancer
Iterative Health develops and deploys AI-powered tools for gastrointestinal (GI) care. Its main product is SKOUT®, an FDA-cleared device that helps doctors find adenomas (polyps) during GI procedures, supporting clinical judgment rather than replacing it. The company also offers AI-enabled documentation and data standardization technologies to improve the quality of patient care and to streamline clinical trials, enabling consistent reporting across institutions. By combining AI image analysis, data-driven insights, and streamlined research workflows, Iterative Health aims to improve colorectal cancer prevention and diagnosis and to extend high-quality GI care to underserved populations around the world.
Explore more opportunities at Iterative Health